Dentsply Sirona Inc
XRAY: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| TW | LOCK|z$ | LOCK|#R>Gq<q |
Dentsply Sirona Earnings: 2026 Looks to Be Another Transition Year as Recovery Still in the Works
Dentsply Sirona delivered revenue and adjusted earnings per share growth of 6% and 5%, respectively, during the fourth quarter. Full-year guidance includes $3.55 billion in revenue and $1.45 in EPS, both at the midpoints, reflecting 3% and 8% declines.
